234 related articles for article (PubMed ID: 21368753)
1. Immunoconjugates against solid tumors: mind the gap.
Ricart AD
Clin Pharmacol Ther; 2011 Apr; 89(4):513-23. PubMed ID: 21368753
[TBL] [Abstract][Full Text] [Related]
2. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
Ricart AD; Tolcher AW
Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
[TBL] [Abstract][Full Text] [Related]
3. Antibody-targeted drugs for the therapy of cancer.
Pietersz GA; Krauer K
J Drug Target; 1994; 2(3):183-215. PubMed ID: 7812691
[TBL] [Abstract][Full Text] [Related]
4. [An overview of antibody therapy against cancer].
Taniguchi H; Imai K
Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
[TBL] [Abstract][Full Text] [Related]
5. Potent antibody drug conjugates for cancer therapy.
Senter PD
Curr Opin Chem Biol; 2009 Jun; 13(3):235-44. PubMed ID: 19414278
[TBL] [Abstract][Full Text] [Related]
6. Cancer stromal targeting (CAST) therapy.
Matsumura Y
Adv Drug Deliv Rev; 2012 Jun; 64(8):710-9. PubMed ID: 22212902
[TBL] [Abstract][Full Text] [Related]
7. [Application of monoclonal antibody for drug delivery system--missile therapy for cancer].
Yamaguchi T; Takahashi T; Kitamura K; Otsuji E; Sakakura C; Okamoto K; Tsuruta H; Ichikawa D; Matsumura H; Yamamoto K; Nishida T; Kimura A
Nihon Rinsho; 1998 Mar; 56(3):638-43. PubMed ID: 9549349
[TBL] [Abstract][Full Text] [Related]
8. The next generation of antibody-drug conjugates comes of age.
Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
[TBL] [Abstract][Full Text] [Related]
9. Naptumomab estafenatox: a new immunoconjugate.
Robinson MK; Alpaugh RK; Borghaei H
Expert Opin Biol Ther; 2010 Feb; 10(2):273-9. PubMed ID: 20053143
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.
Stan AC; Radu DL; Casares S; Bona CA; Brumeanu TD
Cancer Res; 1999 Jan; 59(1):115-21. PubMed ID: 9892195
[TBL] [Abstract][Full Text] [Related]
11. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
[TBL] [Abstract][Full Text] [Related]
12. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibody for cancer treatment].
Achiwa H; Sato S; Ueda R
Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
[TBL] [Abstract][Full Text] [Related]
14. [Radiolabeled antibodies for cancer treatment].
Barbet J; Chatal JF; Kraeber-Bodéré F
Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
[TBL] [Abstract][Full Text] [Related]
15. Antibody-targeted drugs and drug resistance--challenges and solutions.
Shefet-Carasso L; Benhar I
Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
[TBL] [Abstract][Full Text] [Related]
16. Investigational antibody drug conjugates for solid tumors.
Sapra P; Hooper AT; O'Donnell CJ; Gerber HP
Expert Opin Investig Drugs; 2011 Aug; 20(8):1131-49. PubMed ID: 21599617
[TBL] [Abstract][Full Text] [Related]
17. [Immunoconjugates, drug-armed antibodies to fight against cancer].
Haeuw JF; Caussanel V; Beck A
Med Sci (Paris); 2009 Dec; 25(12):1046-52. PubMed ID: 20035677
[TBL] [Abstract][Full Text] [Related]
18. Antibody conjugate therapeutics: challenges and potential.
Teicher BA; Chari RV
Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy of cancer.
Weiner LM
Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
Gupta B; Torchilin VP
Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]